Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CorMedix Inc.CRMD · Entity 5280 | Chief Financial Officer | January 10, 2025 | January 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CorMedix Inc.
Report date January 10, 2025 · Filed January 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 95,270 |
Reported balance
After 2025-01-10 transaction · row 1
1 source rowRow 1 · 2025-01-10 · Tax withholding · Disposed 6,515 · Balance 95,270 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2025 Filed Jan 14, 2025 19:17 UTC | CorMedix Inc. CRMD · Entity 5280 | Tax withholdingCommon Stock | 6,515 | $11.19 | $72,902.85 |
DisclosureSEC source: 0001213900-25-003535 · ownership.xml · nonDerivative · entry 1 David Matthew T · CIK 0001811612 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,270 Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC | CorMedix Inc. CRMD · Entity 5280 | Tax withholdingCommon Stock | 8,648 | $8.22 | $71,086.56 |
DisclosureSEC source: 0001213900-25-001356 · ownership.xml · nonDerivative · entry 2 David Matthew T · CIK 0001811612 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,786 Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-001356 · ownership.xml · nonDerivative · entry 1 David Matthew T · CIK 0001811612 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,434 F1 · price: These shares represent restricted stock units granted on 01/02/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 20:10 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 100,000 | $0.00 Strike: $3.47 | $0.00 |
DisclosureSEC source: 0000929638-24-000133 · form4.xml · derivative · entry 3 David Matthew T · CIK 0001811612 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-01-11 F2 · derivative.exercise_date: These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 20:10 UTC | CorMedix Inc. CRMD · Entity 5280 | Tax withholdingCommon Stock | 5,216 | $3.47 | $18,099.52 |
DisclosureSEC source: 0000929638-24-000133 · form4.xml · nonDerivative · entry 2 David Matthew T · CIK 0001811612 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,934 Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 20:10 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-24-000133 · form4.xml · nonDerivative · entry 1 David Matthew T · CIK 0001811612 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,150 F1 · price: These restricted stock units ("RSUs") were granted on 01/12/2024. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These RSUs vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 18:53 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 125,000 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001213900-23-003547 · ownership.xml · derivative · entry 2 David Matthew T · CIK 0001811612 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2033-01-14 F1 · derivative.exercise_date: These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 16:09 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | Not disclosed | $0.00 Strike: $4.03 | $100,000.00 |
DisclosureSEC source: 0001213900-22-008933 · doc4.xml · derivative · entry 2 David Matthew T · CIK 0001811612 · Interim CEO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-02-18 F4 · derivative.exercise_date: These options were granted on 2/18/2022. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 18:44 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 1,000 | $4.50 | $4,500.00 |
DisclosureSEC source: 0001213900-21-064007 · doc4.xml · nonDerivative · entry 1 David Matthew T · CIK 0001811612 · Interim CEO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,150 Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 18:44 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 1,000 | $4.50 | $4,500.00 |
DisclosureSEC source: 0001213900-21-064006 · doc4.xml · nonDerivative · entry 1 David Matthew T · CIK 0001811612 · Interim CEO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,150 Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 09:53 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 1,000 | $5.07 | $5,070.00 |
DisclosureSEC source: 0001213900-21-060724 · doc4.xml · nonDerivative · entry 1 David Matthew T · CIK 0001811612 · Interim CEO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 Read SEC document |
| November 01, 2021 Filed Nov 10, 2021 17:24 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 125,000 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001213900-21-058209 · doc4.xml · derivative · entry 2 David Matthew T · CIK 0001811612 · Interim CEO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2031-11-01 F1 · derivative.exercise_date: These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 20:00 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 80,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002050 · doc4.xml · derivative · entry 2 David Matthew T · CIK 0001811612 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 08:38 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 1,150 | $4.07 | $4,680.50 |
DisclosureSEC source: 0001213900-20-025532 · doc4.xml · nonDerivative · entry 1 David Matthew T · CIK 0001811612 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150 Read SEC document |
| May 11, 2020 Filed May 13, 2020 16:18 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 125,000 | $4.08 Strike: $4.08 | $510,000.00 |
DisclosureSEC source: 0001213900-20-011996 · doc4.xml · derivative · entry 2 David Matthew T · CIK 0001811612 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 16:18 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 125,000 | $5.63 Strike: $5.63 | $703,750.00 |
DisclosureSEC source: 0001213900-20-011996 · doc4.xml · derivative · entry 1 David Matthew T · CIK 0001811612 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.